A Clinical--Metabolic Approach to Determining Calcium Requirements: Interplay of the Glucose Axis, PTH--Vitamin D Signalling and Bone Mineral Density
Abstract
Calcium homeostasis is maintained by an endocrine network comprising parathyroid hormone (PTH), calcitriol and calcitonin, which defends serum calcium at the expense of skeletal reserves. Serum calcium is therefore an unreliable indicator of nutritional calcium status, and empirical supplementation remains common. This narrative review proposes a clinical--metabolic approach to estimating individual calcium requirements that integrates bone mineral density (BMD), vitamin D status and the compensatory PTH response. We make three contributions. First, we present a sigmoidal phosphate--PTH model in which a glucose-dependent gain term (Δkgluc) captures the heightened parathyroid sensitivity associated with dysglycaemia, and we illustrate it with simulated values for healthy adults, women and individuals with gluco-osteoporosis. Second, we translate the model into a four-step decision algorithm that frames the intake gap as a net balance of intestinal absorption, renal excretion and bone turnover. Third, we incorporate the osteocyte--osteoblast bioenergetic axis (sclerostin/Wnt signalling, GLUT1-mediated glucose uptake, aerobic glycolysis and osteocalcin--insulin crosstalk) to explain why calcium supplementation may be ineffective when cellular energy supply or insulin sensitivity is impaired. The framework aims to prevent secondary hyperparathyroidism, avoid over supplementation and preserve skeletal integrity. The model values are simulated and require prospective clinical validation.
Related
- Determining the j-Specific Unoccupied 5f Electronic Structure in Actinides
- A Stochastic Approach for Determining the Quark Confinement Potential of Charmonia
- An Inverse Problem for Determining the Piston Speed from a Given Lipschitz Leading Shock
- Explosive Synchronization in Inertial Kuramoto Models: Determining Resilience in Power Grids
- Determining Critical Temperature Differences of Low-Temperature-Differential Stirling Engines: Nonlinear Dynamics Approach
BibTeX
@misc{cruz2026clinicalmetabolic,
title = {{A Clinical--Metabolic Approach to Determining Calcium Requirements: Interplay of the Glucose Axis, PTH--Vitamin D Signalling and Bone Mineral Density}},
author = {Alex Velez Cruz and Oscar Dam and Jairo Rondon},
howpublished = {arXiv},
year = {2026},
month = oct,
doi = {10.48550/arxiv.2610.03963},
eprint = {2610.03963},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2610.03963},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - UNPB
TI - A Clinical--Metabolic Approach to Determining Calcium Requirements: Interplay of the Glucose Axis, PTH--Vitamin D Signalling and Bone Mineral Density
AU - Alex Velez Cruz
AU - Oscar Dam
AU - Jairo Rondon
PY - 2026
DA - 2026/10/02
PB - arXiv
DO - 10.48550/arxiv.2610.03963
UR - https://arxiv.org/abs/2610.03963
AB - Calcium homeostasis is maintained by an endocrine network comprising parathyroid hormone (PTH), calcitriol and calcitonin, which defends serum calcium at the expense of skeletal reserves. Serum calcium is therefore an unreliable indicator of nutritional calcium status, and empirical supplementation remains common. This narrative review proposes a clinical--metabolic approach to estimating individual calcium requirements that integrates bone mineral density (BMD), vitamin D status and the compensatory PTH response. We make three contributions. First, we present a sigmoidal phosphate--PTH model in which a glucose-dependent gain term (Δk_gluc) captures the heightened parathyroid sensitivity associated with dysglycaemia, and we illustrate it with simulated values for healthy adults, women and individuals with gluco-osteoporosis. Second, we translate the model into a four-step decision algorithm that frames the intake gap as a net balance of intestinal absorption, renal excretion and bone turnover. Third, we incorporate the osteocyte--osteoblast bioenergetic axis (sclerostin/Wnt signalling, GLUT1-mediated glucose uptake, aerobic glycolysis and osteocalcin--insulin crosstalk) to explain why calcium supplementation may be ineffective when cellular energy supply or insulin sensitivity is impaired. The framework aims to prevent secondary hyperparathyroidism, avoid over supplementation and preserve skeletal integrity. The model values are simulated and require prospective clinical validation.
ER -